Vidadi Yusibov Selected Research

Hemagglutinins (Hemagglutinin)

1/2017	Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.
11/2014	Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
5/2014	A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
1/2013	Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique.
5/2012	A plant-based system for rapid production of influenza vaccine antigens.
4/2012	Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
4/2012	Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hosts.
11/2011	Co-expression of multiple target proteins in plants from a tobacco mosaic virus vector using a combination of homologous and heterologous subgenomic promoters.
1/2011	Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.
2/2009	Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vidadi Yusibov Research Topics

Disease

18	Human Influenza (Influenza) 01/2019 - 01/2007
13	Infections 01/2020 - 01/2008
8	Malaria 01/2023 - 01/2011
7	Influenza in Birds (Avian Flu) 01/2019 - 02/2009
5	Communicable Diseases (Infectious Diseases) 01/2016 - 01/2013
4	Anthrax 01/2016 - 03/2005
3	Virus Diseases (Viral Diseases) 01/2020 - 06/2008
3	Neoplasms (Cancer) 01/2016 - 04/2007
2	Rabies (Hydrophobia) 01/2022 - 03/2011
1	Edema (Dropsy) 01/2022
1	Ebola Hemorrhagic Fever 01/2020
1	Lymphopenia (Lymphocytopenia) 12/2019
1	Encephalitis (Encephalitis, Rasmussen) 12/2019
1	Fever (Fevers) 12/2019
1	Viremia 12/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Yellow Fever 01/2018
1	Gaucher Disease (Gaucher's Disease) 10/2017
1	Respiratory Syncytial Virus Infections 02/2016
1	Noncommunicable Diseases 12/2012
1	Hemolysis 05/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2011
1	Hepatitis B 03/2011
1	Dental Caries (Decay, Dental) 03/2011
1	Newcastle Disease 03/2011
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 05/2009
1	Plague (Bubonic Plague) 05/2009
1	Zoonoses 04/2009
1	Insulinoma 02/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2007
1	Animal Diseases 01/2006
1	Tetanus 08/2005

Drug/Important Bio-Agent (IBA)

38	VaccinesIBA 01/2023 - 01/2006
21	AntigensIBA 01/2023 - 08/2005
12	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 01/2008
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2007
6	Subunit VaccinesIBA 01/2023 - 01/2008
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2015 - 06/2008
4	Monoclonal AntibodiesIBA 02/2016 - 03/2005
3	AntibodiesIBA 01/2018 - 02/2009
2	Antiviral Agents (Antivirals)IBA 10/2015 - 01/2011
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2015 - 01/2013
2	Silicon Dioxide (Silica)FDA LinkGeneric 05/2014 - 01/2013
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 05/2014 - 07/2011
2	bis(3',5')-cyclic diguanylic acidIBA 05/2014 - 07/2011
2	Immunoglobulin G (IgG)IBA 05/2012 - 04/2007
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2022
1	Polysaccharides (Glycans)IBA 01/2020
1	EpitopesIBA 01/2020
1	Combined Antibody TherapeuticsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	SolutionsIBA 01/2019
1	avian influenza A virus hemagglutininIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2018
1	Plasmodium falciparum Pfs25 proteinIBA 11/2017
1	taliglucerase alfaIBA 10/2017
1	SuspensionsIBA 10/2017
1	Peptides (Polypeptides)IBA 02/2016
1	Antisense RNA (Anti-Sense RNA)IBA 11/2011
1	Green Fluorescent ProteinsIBA 11/2011
1	Zanamivir (Relenza)FDA Link 01/2011
1	Neuraminidase (Sialidase)IBA 01/2011
1	Biological Warfare AgentsIBA 05/2009
1	Carrier Proteins (Binding Protein)IBA 01/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2007
1	Tyrosine (L-Tyrosine)FDA Link 02/2007
1	AutoantigensIBA 02/2007
1	GlucuronidaseIBA 08/2005

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2016
2	Injections 03/2011 - 04/2007
1	Immunotherapy 05/2009